Chronic limb-threatening ischemia (CLTI) is the end-stage presentation of peripheral artery disease and requires comprehensive care. Despite advancements in treatments, providing timely and equitable care remains challenging. Ongoing research and interdisciplinary collaboration are vital for improving outcomes. Implementing strategies that combine appropriate diagnostics, advanced and innovative revascularization techniques, guideline-directed medical therapies, and efforts to tackle socioeconomic disparities can better address patient needs and enhance quality and quantity of life. This multifaceted approach offers promise for improved long-term outcomes in CLTI patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.iccl.2024.11.011 | DOI Listing |
J Vasc Bras
February 2025
Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brasil.
Background: Pedal acceleration time (PAT) is a novel indicator of peripheral arterial disease in the lower limbs. Elevated PAT values are associated with worse limb ischemia. Arterial stiffness indexes are another class of indicators recently studied in patients with chronic limb-threatening ischemia (CLTI).
View Article and Find Full Text PDFCirc Rep
March 2025
Department of Vascular Surgery, Asahikawa Medical University Hokkaido Japan.
Background: Acute lower extremity limb ischemia (ALI) is a common vascular surgery emergency, primarily caused by embolism or atherosclerotic in situ thrombosis-acute on chronic limb ischemia (AoCLI). This study aimed to examine the clinical features and treatment challenges of AoCLI.
Methods And Results: Between January 2014 and December 2022, 73 patients with AoCLI (n=35) or embolic ALI (n=38) were analyzed.
Ann Vasc Surg
March 2025
Center for Learning and Excellence in Vascular and Endovascular Surgery (CLEVER), Department of Surgery, Division of Vascular and Endovascular Surgery, University of California San Diego Health System, San Diego, CA. Electronic address:
Introduction: Aortofemoral or aortoiliac bypasses (AFB/AIB) are considered the gold standard treatment for patients with aortoiliac occlusive disease. Myocardial infarction (MI) is a postoperative risk in AFB/AIB surgeries and preoperative stress testing (PST) is frequently utilized to inform operative planning and pre-operative risk discussions. The aim of this study is to assess the utility of PST in determining outcomes following AFB/AIB in patients with chronic limb threatening ischemia (CLTI).
View Article and Find Full Text PDFAnn Vasc Surg
March 2025
Center for Learning and Excellence in Vascular and Endovascular Surgery (CLEVER), Department of Surgery, Division of Vascular and Endovascular Surgery, University of California San Diego Health System, San Diego, CA. Electronic address:
Introduction: This study aims to evaluate perioperative and one-year outcomes of patients undergoing aortobiiliac bypass (ABIB) in comparison with aortobifemoral bypass (ABFB) for the treatment of aortoiliac occlusive disease, using data from the Vascular Quality Initiative (VQI).
Methods: All patients undergoing ABIB and ABFB bypasses (2010-2023) were queried. The primary outcome was surgical site infections (SSI).
Tissue Eng Part C Methods
March 2025
Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, USA.
Sympathetic innervation plays a critical role in regulating vascular function, yet its influence on vascular regeneration and reinnervation following ischemic injury remains poorly understood. This study develops and validates murine models of localized sympathetic denervation using 6-hydroxydopamine (6-OHDA) to enable study of the sympathetic nervous system's impact on vascular systems during tissue repair. Two methods of 6-OHDA administration were employed: a single topical application during open surgery and minimally invasive weekly subcutaneous injections.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!